William Dean Hansen - 21 Oct 2025 Form 4 Insider Report for Performant Healthcare Inc (PHLT)

Reporting relationship: Director
Issuer ticker: PHLT
Reported as of: 21 Oct 2025
Net transaction value: -$276,024
SEC form: 4
Accepted by SEC: 21 Oct 2025, 12:11:37 UTC
Prior SEC filing: 28 Jul 2025
Next SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Rohit Ramchandani, Attorney-in-Fact for William D. Hansen

Key filing fact

William Dean Hansen filed Form 4 for Performant Healthcare Inc (PHLT) on 21 Oct 2025.

Key facts

This page summarizes William Dean Hansen's Form 4 filing for Performant Healthcare Inc (PHLT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Oct 2025, 12:11.

Change

Previous filing in this sequence was filed on 28 Jul 2025.
Current net transaction value: -$276,024.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001265886 Primary reporting owner

HANSEN WILLIAM DEAN

Relationship: Director
Address: 900 SOUTH PINE ISLAND ROAD, SUITE 150, PLANTATION
Signature: /s/ Rohit Ramchandani, Attorney-in-Fact for William D. Hansen
Signature date: 21 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHLT transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -464,115
Change %: -100%
Price
Shares after: 0
Date: 21 Oct 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHLT transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value: $276,024
Shares: -35,616
Change %: -100%
Price: $7.75
Shares after: 0
Date: 21 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,616
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

William Dean Hansen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").

Footnote F2

Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.

Footnote F3

Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.

Footnote F4

All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.